An eight-week, open-label, prospective case series of acamprosate calcium as monotherapy for patients with comorbid anxiety symptoms and alcohol misuse: an evaluation for alcohol sobriety and anxiolysis.
Schwartz
Thomas L
TL
Chilton
Mark
M
Aneja
Alka
A